Advanced Cell Technology Awarded Federal Grant from National Institutes of Health to Accelerate Embryonic Stem Cell Research

ALAMEDA, Calif.—(BUSINESS WIRE)—Advanced Cell Technology, Inc. (OTCBB:ACTC – News), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, has been awarded a research grant from the National Institutes of Health (NIH) in the amount of $204,439 in conjunction with a research project currently underway with one of its academic partners, The Burnham Institute of Medical Research (Burnham Institute).

Source: Advanced Cell Technology